27P-14792-32447

5 vaccinations 15 coded responses 45 check-ins 13 free-text entries 3 call cases

Sex: Female
Age at first dose: 66+
ZIP prefix: 630 / MO
Registered: 2021-03-03

Relationship: Self
Race: Black or African American
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2624888 (opens in a new window)	medium	10 / 11	9	2 of 6 VAERS symptoms	same dose (5)	MO matches	2022-10-29 / 2023-01-15 / 2023-05-02 received the same day as the last call	case 615934

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-03
Registered in v-safe
2021-03-03
Dose 1 — Pfizer-BioNTech
2021-03-03
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-04
Survey response — days 1–6 daily, dose 1
MedDRA: Hyperhidrosis — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Severe sweating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-05
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Abdominal pain

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness, Abdominal pain

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-10
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-17
Survey response — day 14, dose 1
MedDRA: Blood pressure increased — Feeling: Fair · Be unable to do your normal daily activities

Free text: Blood pressure is running higher

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Dose 2 — Pfizer-BioNTech
2021-03-24
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-26
Survey response — days 1–6 daily, dose 2
MedDRA: Blood pressure increased — Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Higher blood pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-28
Survey response — days 1–6 daily, dose 2
MedDRA: Blood pressure increased — Feeling: Good · Fatigue or tiredness

Free text: Higher blood pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-29
Survey response — days 1–6 daily, dose 2
MedDRA: Gait disturbance, Hypertension, Pollakiuria — Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: High blood pressurer, unsteady gait, frequent urination

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-31
Survey response — day 7, dose 2
MedDRA: Blood pressure increased — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Higher blood pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Survey response — day 14, dose 2
MedDRA: Blood pressure increased — Feeling: Good · Be unable to do your normal daily activities

Free text: Increase bp

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-22
Survey response — day 28, dose 2
MedDRA: Blood pressure increased — Feeling: Fair · Be unable to do your normal daily activities

Free text: Blood pressure up to 151

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-05
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-23
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-24
Survey response — 6 months, dose 2
MedDRA: Abdominal pain upper, Diarrhoea — Feeling: Good · Be unable to do your normal daily activities

Free text: Issues with diarrhea & stomach ache

MedDRA releases: 2024-11 · check-in free text available
2021-11-13
Dose 3 — Pfizer-BioNTech
2022-03-24
Survey response — 12 months, dose 2
MedDRA: Blood pressure fluctuation, Chills, Dizziness, Fatigue, Heart rate increased — Feeling: Good · Be unable to do your normal daily activities

Free text: Rapid heart beat, dizziness, tiredness, up & down Bp, chills

MedDRA releases: 2024-11 · check-in free text available
2022-05-20
Dose 4 — Pfizer-BioNTech
2022-05-21
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-05-22
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-05-23
Survey response — days 1–6 daily, dose 4
MedDRA: Abdominal pain upper — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Stomach pain late yesterday

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-05-25
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-05-26
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-05-27
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-06-03
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-06-10
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-06-17
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-06-26
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-07-01
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-08-19
Survey response — 3 months, dose 4
MedDRA: Arthralgia, Blood pressure increased, Disturbance in attention, Fatigue, Headache, Peripheral swelling — Feeling: Good · Be unable to do your normal daily activities

Free text: Elevated blood pressure; fatigue; inability to concentrate; arthritic pain in right hand; hand swelling both hands; headaches

MedDRA releases: 2024-11 · check-in free text available
2022-10-29
Dose 5 — Pfizer-BioNTech
2022-11-18
Health check-in — 6 months, dose 4
Feeling: Fair

Adult check-in
2022-11-18
Health check-in — day 14, dose 5
Feeling: Fair

Adult check-in
2022-11-19
Health check-in — day 21, dose 5
Feeling: Good

Adult check-in
2022-11-26
Health check-in — day 28, dose 5
Feeling: Good

Adult check-in
2022-12-03
Survey response — day 35, dose 5
MedDRA: Back pain, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Lower left back pain is worse requiring more pain meds · Healthcare visit (other): Office visit - PA

MedDRA releases: 2024-11 · check-in free text available
2022-12-03
Report sent to call center — day 35, dose 5
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-12-06
Call 1 — Left Voicemail
2022-12-06
Callback requested for
02:30PM ET
2022-12-10
Health check-in — day 42, dose 5
Feeling: Good

Adult check-in
2023-01-28
Survey response — 3 months, dose 5
MedDRA: Asthma, COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-01-28
Report sent to call center — 3 months, dose 5
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-01-30
Call successful
Completed over the phone
2023-01-30
Call successful
Completed over the phone
2023-04-29
Survey response — 6 months, dose 5
MedDRA: Cough, Lacrimation increased, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11
2023-04-29
Report sent to call center — 6 months, dose 5
Get care from a doctor or other healthcare professional

1 call case(s)
2023-05-02
Call 1 — Requested Callback
2023-05-02
Callback requested for
03:00PM ET
2023-05-02
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-03	Pfizer-BioNTech
2	2021-03-24	Pfizer-BioNTech
3	2021-11-13	Pfizer-BioNTech	No
4	2022-05-20	Pfizer-BioNTech	No
5	2022-10-29	Pfizer-BioNTech	No

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-04

Systemic reaction (other): Severe sweating

Release 5 — day 14, dose 1

2021-03-17

Symptoms: Blood pressure is running higher

Release 6 — days 1–6 daily, dose 2

2021-03-26

Systemic reaction (other): Higher blood pressure

2021-03-28

Systemic reaction (other): Higher blood pressure

2021-03-29

Systemic reaction (other): High blood pressurer, unsteady gait, frequent urination

Release 6 — day 7, dose 2

2021-03-31

Systemic reaction (other): Higher blood pressure

Release 7 — day 14, dose 2

2021-04-07

Symptoms: Increase bp

Release 7 — day 28, dose 2

2021-04-22

Symptoms: Blood pressure up to 151

Release 9 — 6 months, dose 2

2021-09-24

Symptoms: Issues with diarrhea & stomach ache

Release 11 — 12 months, dose 2

2022-03-24

Symptoms: Rapid heart beat, dizziness, tiredness, up & down Bp, chills

Release 11 — days 1–6 daily, dose 4

2022-05-23

Systemic reaction (other): Stomach pain late yesterday

Release 12 — 3 months, dose 4

2022-08-19

Symptoms: Elevated blood pressure; fatigue; inability to concentrate; arthritic pain in right hand; hand swelling both hands; headaches

Release 12 — day 35, dose 5

2022-12-03

Symptoms: Lower left back pain is worse requiring more pain meds

Healthcare visit (other): Office visit - PA

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Abdominal pain upper	·	·	✓
SD	Arthralgia	·	·	✓
SD	Asthma	·	·	✓
SD	Back pain	·	·	✓
SD	Blood pressure fluctuation	·	·	✓
SD	Blood pressure increased	✓	✓	✓
SD	Chills	·	·	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Disturbance in attention	·	·	✓
SD	Dizziness	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Heart rate increased	·	·	✓
SD	Lacrimation increased	·	·	✓
SD	Peripheral swelling	·	·	✓
SRO	Abdominal pain upper	·	·	✓
SRO	Blood pressure increased	✓	✓	✓
SRO	Gait disturbance	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓
SRO	Hypertension	✓	✓	✓
SRO	Pollakiuria	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release